PAVmed (PAVM) Liabilities and Shareholders Equity (2015 - 2025)
PAVmed's quarterly Liabilities and Shareholders Equity came in at $38.8 million in Q4 2025, up 26.59% year-on-year from $30.7 million in Q4 2024, and up 1.95% quarter-over-quarter from $38.1 million in Q3 2025.
PAVmed has reported Liabilities and Shareholders Equity for 11 years, with the latest figure at $38.8 million in Q4 2025.
- For the quarter ending Q4 2025, Liabilities and Shareholders Equity rose 26.59% year-over-year to $38.8 million; the trailing twelve-month figure through Dec 2025 stood at $173.6 million (up 31.14% YoY), and the FY2025 full-year result was $38.8 million, up 26.59% from the prior year.
- Liabilities and Shareholders Equity for Q4 2025 stood at $38.8 million, up from $38.1 million in the prior quarter.
- The five-year high for Liabilities and Shareholders Equity was $87.0 million in Q4 2021, with the low at $25.0 million in Q3 2024.
- Average Liabilities and Shareholders Equity over 5 years is $51.1 million, with a median of $45.6 million recorded in 2021.
- Year-over-year, Liabilities and Shareholders Equity jumped 433.34% in 2021 and sank 42.94% in 2024.
- Tracing PAVM's Liabilities and Shareholders Equity over 5 years: stood at $87.0 million in 2021, then slumped by 37.94% to $54.0 million in 2022, then sank by 38.65% to $33.1 million in 2023, then decreased by 7.42% to $30.7 million in 2024, then increased by 26.59% to $38.8 million in 2025.
- The last three Liabilities and Shareholders Equity figures came in at $38.8 million (Q4 2025), $38.1 million (Q3 2025), and $43.9 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 110.43 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 46.29 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 91.49 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 44.35 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 13.32 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 31.92 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 6.63 Bn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 37.13 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 10.74 Bn |
| 10 | PAVmed | 4.15 Mn | -9.02 Mn | -703,000.00 | 38.81 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 38.81 Mn |
| Sep 30, 2025 | 38.07 Mn |
| Jun 30, 2025 | 43.89 Mn |
| Mar 31, 2025 | 52.82 Mn |
| Dec 31, 2024 | 30.66 Mn |
| Sep 10, 2024 | 25.04 Mn |
| Jun 30, 2024 | 39.41 Mn |
| Mar 31, 2024 | 37.25 Mn |
| Dec 31, 2023 | 33.12 Mn |
| Sep 30, 2023 | 42.02 Mn |
| Jun 30, 2023 | 53.68 Mn |
| Mar 31, 2023 | 65.29 Mn |
| Dec 31, 2022 | 53.98 Mn |
| Sep 30, 2022 | 72.47 Mn |
| Jun 30, 2022 | 82.45 Mn |
| Mar 31, 2022 | 84.33 Mn |
| Dec 31, 2021 | 86.98 Mn |
| Sep 30, 2021 | 42.99 Mn |
| Jun 30, 2021 | 47.37 Mn |
| Mar 31, 2021 | 51.37 Mn |
| Dec 31, 2020 | 19.78 Mn |
| Sep 30, 2020 | 10.50 Mn |
| Jun 30, 2020 | 8.88 Mn |
| Mar 31, 2020 | 10.11 Mn |
| Dec 31, 2019 | 7.24 Mn |
| Sep 30, 2019 | 4.41 Mn |
| Jun 30, 2019 | 7.06 Mn |
| Mar 31, 2019 | 4.36 Mn |
| Dec 31, 2018 | 8.50 Mn |
| Sep 30, 2018 | 9.40 Mn |
| Jun 30, 2018 | 11.24 Mn |
| Mar 31, 2018 | 3.76 Mn |
| Dec 31, 2017 | 1.64 Mn |
| Sep 30, 2017 | 3.23 Mn |
| Jun 30, 2017 | 226,480.00 |
| Mar 31, 2017 | 1.09 Mn |
| Dec 31, 2016 | 870,419.00 |
| Sep 30, 2016 | 1.99 Mn |
| Jun 30, 2016 | 3.15 Mn |
| Mar 31, 2016 | 781,297.00 |
| Dec 31, 2015 | 1.21 Mn |